Breast Surgery Practice Questions

Q: What is true about a modified radical mastectomy?

Pectoralis minor is divided. **Explanation:** Modified Radical Mastectomy (MRM) is the current standard surgical procedure for operable breast cancer. It involves the removal of the entire breast tissue (including the nipple-areola complex and fascia of the pectoralis major) along with an axillary lymph node dissection. **Why Option C is Correct:** In the **Auchincloss modification** of MRM, the pectoralis minor is retracted. However, in the **Patey modification**, the **pectoralis minor is either divided or removed** to facilitate complete access to the Level III (apical) axillary lymph nodes. This allows for a thorough clearance of the axilla while still preserving the pectoralis major muscle. **Analysis of Incorrect Options:** * **A. Pectoralis major is removed:** This is a feature of the **Halsted Radical Mastectomy**, not MRM. In MRM, the pectoralis major is strictly preserved, which leads to better cosmetic and functional outcomes. * **B. Axillary lymph nodes are preserved:** This is incorrect. MRM by definition includes the clearance of Level I, II, and sometimes Level III axillary lymph nodes. Preservation occurs in Simple (Total) Mastectomy. * **D. Internal mammary lymph nodes are removed:** These are removed in an **Extended Radical Mastectomy** (Urban’s procedure), which is rarely performed today due to high morbidity and lack of survival benefit. **NEET-PG High-Yield Pearls:** * **Patey’s MRM:** Removes Pectoralis minor + Level I, II, III nodes. * **Auchincloss MRM:** Preserves Pectoralis minor + removes Level I, II nodes. * **Nerves at risk during MRM:** Long thoracic nerve (Serratus anterior - Winging of scapula), Thoracodorsal nerve (Latissimus dorsi), and Intercostobrachial nerve (most commonly injured; causes numbness of the inner arm).

Q: In a patient with Ca Breast, ipsilateral supraclavicular lymph nodes are positive. Which of the following represents the stage of malignancy in this patient?

Stage III C. ### Explanation The staging of Breast Cancer follows the **AJCC TNM Classification (8th Edition)**. The involvement of **ipsilateral supraclavicular lymph nodes** is a critical anatomical landmark in determining the N-stage and overall clinical stage. #### Why Stage III C is Correct? According to the TNM staging system: * **N3a:** Metastasis in ipsilateral infraclavicular lymph node(s). * **N3b:** Metastasis in ipsilateral internal mammary and axillary lymph nodes. * **N3c:** Metastasis in **ipsilateral supraclavicular lymph node(s)**. Any T (Tumor size) combined with **N3** nodal status automatically categorizes the malignancy as **Stage III C**. This represents advanced regional spread but is still considered "locoregionally advanced" rather than distant metastasis. #### Why Other Options are Incorrect: * **Stage II:** Represents smaller tumors (T1-T2) with limited mobile axillary nodes (N0-N1). Supraclavicular involvement is far too advanced for this stage. * **Stage III B:** This stage is defined by **T4 status** (tumor of any size with direct extension to the chest wall or skin, including inflammatory breast cancer) with N0-N2 nodes. It does not include N3 nodal involvement. * **Stage IV:** This represents **distant metastasis (M1)**. While supraclavicular nodes were once considered M1, they are now classified as **N3 (Stage III C)**. Only contralateral supraclavicular nodes or nodes beyond the regional basin (e.g., cervical, lungs, liver) would signify Stage IV. #### High-Yield Clinical Pearls for NEET-PG: * **N1:** Mobile ipsilateral level I, II axillary nodes. * **N2:** Fixed/matted ipsilateral axillary nodes or clinically detected internal mammary nodes. * **N3:** Infraclavicular, Supraclavicular, or both Internal Mammary + Axillary nodes. * **Prognostic Significance:** Stage III C is the most advanced stage of non-metastatic breast cancer. Treatment usually begins with Neoadjuvant Chemotherapy (NACT).

Q: A 56-year-old male patient develops an eccentric hard breast lump over the past few months. A biopsy proves this to be breast carcinoma. What is the approximate incidence of breast cancer in males as a percentage of all breast cancers?

Less than 1%. **Explanation:** **1. Why the Correct Answer is Right:** Male breast cancer (MBC) is a rare clinical entity. Epidemiological data consistently shows that it accounts for **less than 1%** of all breast cancer cases worldwide and approximately 0.1% of all cancer deaths in men. The low incidence is primarily due to the lack of acini and lobules in the normal male breast, which consists mainly of rudimentary ducts. The most common histological subtype in males is **Invasive Ductal Carcinoma (IDC)**, as lobular carcinoma is extremely rare due to the absence of lobules. **2. Why the Incorrect Options are Wrong:** * **B (4%), C (7%), and D (10%):** These percentages significantly overestimate the prevalence. While the incidence of breast cancer in women is high (1 in 8 lifetime risk), the male-to-female ratio remains approximately **1:100**. Choosing these higher values would imply that male breast cancer is a common clinical encounter, which contradicts global oncological statistics. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Risk Factors:** The strongest risk factor for MBC is **BRCA2 mutation** (more common than BRCA1 in males). Other factors include Klinefelter syndrome (highest relative risk), radiation exposure, and hyperestrogenism (e.g., liver cirrhosis, obesity). * **Clinical Presentation:** Typically presents as a **painless, firm, eccentric subareolar lump**. Because of the lack of breast tissue, skin involvement and nipple retraction occur earlier than in females. * **Diagnosis:** Triple assessment (Clinical, Imaging, Core Biopsy) is standard. Mammography in men has high sensitivity. * **Management:** Modified Radical Mastectomy (MRM) is the traditional surgical treatment of choice. Tamoxifen is the mainstay of hormonal therapy, as ~90% of male breast cancers are ER-positive.

Q: What is considered the gold standard flap for breast reconstruction?

DIEP flap. **Explanation:** The **DIEP (Deep Inferior Epigastric Perforator) flap** is currently considered the **gold standard** for autologous breast reconstruction. The underlying medical concept is the preservation of the rectus abdominis muscle. Unlike the TRAM flap, the DIEP flap involves harvesting only skin and fat (angiosome of the deep inferior epigastric artery) while meticulously dissecting the perforators through the muscle. This results in significantly less donor-site morbidity, a lower risk of abdominal wall hernias, and faster recovery. **Analysis of Incorrect Options:** * **TRAM (Transverse Rectus Abdominis Myocutaneous) flap:** Formerly the gold standard, it involves harvesting a portion of the rectus muscle. This leads to increased donor-site weakness and higher rates of postoperative bulge or hernia. * **LD (Latissimus Dorsi) flap:** This is a reliable musculocutaneous flap but often provides insufficient volume for a full breast, frequently requiring a supplementary implant. It also results in a scar on the back and potential shoulder weakness. * **Silicone gel implant:** This is a prosthetic reconstruction, not a flap. While common, it carries risks of capsular contracture, rupture, and lacks the natural feel and longevity of autologous tissue. **Clinical Pearls for NEET-PG:** * **Vascular Basis:** The DIEP flap is based on the **Deep Inferior Epigastric Artery**. * **Free vs. Pedicled:** DIEP is always a **free flap** requiring microsurgical anastomosis (usually to internal mammary vessels). * **Hartrampf Zones:** Knowledge of abdominal wall perfusion zones (I-IV) is critical for TRAM/DIEP flap planning. * **SIEA Flap:** If the Superficial Inferior Epigastric Artery is used, it is called an SIEA flap, which avoids muscle incision entirely but has inconsistent vascular anatomy.

Q: What is the most malignant type of carcinoma of the breast?

Mastitis carcinomatosa. **Explanation:** **Mastitis carcinomatosa**, also known as **Inflammatory Breast Cancer (IBC)**, is the most aggressive and malignant form of breast cancer. It is characterized by rapid clinical onset, where the breast appears red, swollen, and warm, mimicking an infection (mastitis). The underlying pathology involves the widespread blockage of **dermal lymphatics** by tumor emboli, rather than true inflammation. It is classified as T4d in the TNM staging system and is considered systemic at the time of diagnosis, carrying the poorest prognosis among all breast malignancies. **Analysis of Incorrect Options:** * **Paget’s Disease:** This is a superficial manifestation of an underlying ductal carcinoma (usually DCIS or invasive ductal carcinoma). While it indicates malignancy, it is localized to the nipple-areola complex and is not inherently the "most malignant" form. * **Anaplastic Carcinoma:** While these tumors show high-grade cytological features and poor differentiation, they do not typically exhibit the rapid, diffuse lymphatic spread and dismal survival rates characteristic of inflammatory breast cancer. * **Scirrhous Carcinoma:** This is an older term for Invasive Carcinoma of No Special Type (NST) with significant desmoplasia (fibrosis). It is the most common type of breast cancer but is less aggressive than the inflammatory variant. **High-Yield Clinical Pearls for NEET-PG:** * **Clinical Hallmark:** *Peau d'orange* (orange peel appearance) due to cutaneous edema from lymphatic obstruction. * **Diagnosis:** Requires a full-thickness **punch biopsy** of the skin to demonstrate tumor emboli in dermal lymphatics. * **Management:** It is never treated with primary surgery. The standard of care is **Neoadjuvant Chemotherapy (NACT)** followed by Modified Radical Mastectomy (MRM) and Radiotherapy.

Q: Which of the following factors is not included in the TNM staging of carcinoma breast?

Nipple retraction. In the AJCC TNM staging system for breast cancer, staging is determined by the anatomical extent of the disease. The correct answer is **Nipple Retraction** because it is considered a sign of underlying tumor tethering to the ducts rather than an indicator of advanced local invasion (T4 disease). ### **Explanation of Options:** * **Nipple Retraction (Correct):** This is a clinical finding often caused by tumor infiltration of the lactiferous ducts leading to fibrosis. Unlike skin involvement, it does **not** change the T-stage of the tumor. * **Satellite Nodules (Incorrect):** These are defined as separate tumor nodules in the skin ipsilateral to the primary breast tumor. They are classified as **T4b**. * **Inflammation (Incorrect):** Inflammatory breast cancer is a clinical diagnosis characterized by edema (peau d'orange), erythema, and warmth. It is classified as **T4d**. * **Skin Ulceration (Incorrect):** Direct ulceration of the skin by the tumor is a sign of advanced local disease and is classified as **T4b**. ### **High-Yield Clinical Pearls for NEET-PG:** * **T4 Category Breakdown:** * **T4a:** Extension to the chest wall (ribs, intercostals, serratus anterior; *pectoralis muscle involvement alone does not count*). * **T4b:** Edema (peau d'orange), ulceration, or satellite skin nodules. * **T4c:** Both T4a and T4b. * **T4d:** Inflammatory carcinoma. * **Dimpling vs. Retraction:** Skin dimpling or nipple retraction are localized findings and do not upgrade a T1/T2/T3 tumor to T4. * **Internal Mammary Nodes:** If detected clinically or by imaging, they are staged as **N2b** (if axillary nodes are present) or **N3b** (if axillary nodes are also involved).

Q: A 4 cm breast nodule with an ipsilateral mobile lymph node in the axilla, what is the correct TNM staging?

T2N1M0. ### Explanation The TNM staging system for breast cancer is a cornerstone of surgical oncology. To solve this question, we must break down the clinical findings based on the AJCC 8th Edition criteria. **1. Why T2N1M0 is correct:** * **T (Tumor Size):** The nodule is **4 cm**. T2 is defined as a tumor >2 cm but ≤5 cm in its greatest dimension. * **N (Nodal Status):** The presence of an **ipsilateral mobile lymph node** in the axilla corresponds to **N1**. (N2 would involve fixed/matted nodes or internal mammary involvement). * **M (Metastasis):** In the absence of mentioned distant spread, it is staged as **M0**. * Combining these, the stage is **T2N1M0**. **2. Why other options are incorrect:** * **T2N2M0:** Incorrect because N2 requires "fixed" or "matted" axillary nodes, or clinically detected internal mammary nodes in the absence of axillary nodes. "Mobile" nodes are strictly N1. * **T1N1M0:** Incorrect because T1 is defined as a tumor ≤2 cm. This patient’s tumor is 4 cm. * **T3N2M1:** Incorrect on all counts. T3 is >5 cm; N2 implies fixed nodes; M1 implies distant metastasis (not mentioned). **Clinical Pearls for NEET-PG:** * **T-Staging Cheat Sheet:** T1 (≤2 cm), T2 (2–5 cm), T3 (>5 cm), T4 (Extension to chest wall/skin, regardless of size). * **N-Staging Key:** N1 = Mobile axillary nodes; N2 = Fixed/Matted axillary nodes; N3 = Supraclavicular, infraclavicular, or internal mammary + axillary nodes. * **Inflammatory Carcinoma:** Always staged as **T4d**, regardless of the actual size of the underlying mass. * **Dimpling vs. Peau d'orange:** Skin dimpling (tethering to Cooper’s ligament) does not change T-stage, but *Peau d'orange* or skin ulceration classifies it as T4.

Q: Which of the following statements regarding Paget's disease of the breast is true?

It presents with nipple-areolar eczematous changes.. **Explanation:** **Paget’s disease of the breast** is a rare manifestation of breast cancer characterized by the presence of malignant **Paget cells** (large, pale cells with prominent nucleoli) within the epidermis of the nipple-areolar complex. 1. **Why Option B is Correct:** The hallmark clinical presentation is an **eczematous-like lesion** of the nipple that may spread to the areola. It typically presents with erythema, scaling, crusting, or ulceration. Unlike simple eczema, Paget’s disease usually starts at the nipple and spreads peripherally, and it does not respond to topical steroids. 2. **Why the Other Options are Incorrect:** * **Option A:** There is **no clinical or pathological link** between Paget’s disease of the breast and Paget’s disease of the bone (a disorder of bone remodeling). They simply share the same namesake (Sir James Paget). * **Option C:** While Paget’s disease is associated with underlying **Ductal Carcinoma in Situ (DCIS)** in about 40% of cases, the remaining 60% have an underlying **Invasive Ductal Carcinoma (IDC)**. Therefore, axillary lymph node involvement is possible and depends on the stage of the underlying malignancy. * **Option D:** It is rare, accounting for only **1–4%** of all newly diagnosed breast cancers, not 10–15%. **High-Yield Clinical Pearls for NEET-PG:** * **Pathogenesis:** The "Epidermotropic Theory" suggests cancer cells migrate from underlying lactiferous ducts to the nipple skin. * **Diagnosis:** A **full-thickness punch biopsy** of the nipple is the gold standard. * **Key Histology:** PAS-positive, diastase-resistant cells (due to mucin content). * **Management:** Requires evaluation for underlying malignancy via mammography/MRI. Treatment involves mastectomy or breast-conserving surgery (central lumpectomy) plus radiotherapy.

Question 1

What is true about a modified radical mastectomy?

Accepted Answer

Pectoralis minor is divided

Answer

Pectoralis major is removed

Answer

Axillary lymph nodes are preserved

Answer

Internal mammary lymph nodes are removed

Question 2

In a patient with Ca Breast, ipsilateral supraclavicular lymph nodes are positive. Which of the following represents the stage of malignancy in this patient?

Accepted Answer

Stage III C

Answer

Stage II

Answer

Stage III B

Answer

Stage IV

Question 3

A 56-year-old male patient develops an eccentric hard breast lump over the past few months. A biopsy proves this to be breast carcinoma. What is the approximate incidence of breast cancer in males as a percentage of all breast cancers?

Accepted Answer

Less than 1%

Answer

4%

Answer

7%

Answer

10%

Question 4

What is considered the gold standard flap for breast reconstruction?

Accepted Answer

DIEP flap

Answer

TRAM flap

Answer

LD flap

Answer

Silicone gel implant

Question 5

Which of the following has the best prognosis?

Accepted Answer

<1 cm Size, Node -ve, ER/PR +ve, Her 2 Negative

Answer

<1 cm Size, Node -ve, ER/PR -ve, Her 2 Positive

Answer

<2 cm Size, Node -ve, ER/PR +ve, Her 2 Negative

Answer

<2 cm Size, Node -ve, ER/PR -ve, Her 2 positive

Question 6

What is the most malignant type of carcinoma of the breast?

Accepted Answer

Mastitis carcinomatosa

Answer

Paget's disease

Answer

Anaplastic carcinoma

Answer

Scirrhous carcinoma

Question 7

A 9-week pregnant lady presents with a 2.5 cm mass in the upper outer quadrant of her left breast. Ultrasound did not reveal any abnormality. What is the ideal management?

Accepted Answer

Finger-guided core biopsy

Answer

Aspiration of the cyst and reassurance

Answer

Follow-up one month after delivery

Answer

Mammography

Question 8

Which of the following factors is not included in the TNM staging of carcinoma breast?

Accepted Answer

Nipple retraction

Answer

Satellite nodules

Answer

Inflammation

Answer

Skin ulceration

Question 9

A 4 cm breast nodule with an ipsilateral mobile lymph node in the axilla, what is the correct TNM staging?

Accepted Answer

T2N1M0

Answer

T2N2M0

Answer

T1N1M0

Answer

T3N2M1

Question 10

Which of the following statements regarding Paget's disease of the breast is true?

Accepted Answer

It presents with nipple-areolar eczematous changes.

Answer

It usually precedes the development of Paget's disease of bone.

Answer

It does not involve axillary lymph nodes because it is a manifestation of intraductal carcinoma only.

Answer

It accounts for 10-15% of all newly diagnosed breast cancers.

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?